Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Opty / Re: Notes from the PTSC SHM meeting in Chicago - 1/28/2010

"I'm reading this as you want an entirely new BOD seated to start all over with adding layers of managment in order to continue M&A under the umbrella strategy?"

Your read is incorrect. I want a new BoD because the current one has been unable to successfully return value to the shareholders in any sustained fashion and find themselves unable to articulate a solid plan moving forward, much less to execute on one if they are able to figure one out. Yet despite their record, they continue to renumerate themselves at very liberal levels while buying little to no stock in the very company they steward.

They have made mistake upon mistake, and frankly this isn't a 12-step program, where admitting your problem is the 1st step to recovery, it's a public company and they are beholden to shareholders, and they have failed us. They have earned their exit.

Whether a new BoD and management team pursues an umbrella strategy, or some other strategy, if the new members are qualified with skills and contacts associated and complimentary to and aligned with that strategy, and detached from questionable ties and a failed history that this group has, they will likely fare better than the current group.

Share
New Message
Please login to post a reply